The Company
McKesson Health Solutions (MHS) is a business unit of McKesson Corporation, the world’s largest and oldest healthcare services company. We deliver industry-leading clinical evidence and expert technology to help payers and providers collaborate for better healthcare outcomes at lower costs. MHS is one of the leading technology companies in the payer market, with solutions in more than four out of five payers in the country.
Corporate Address
McKesson Health Solutions
McKesson Corporation
275 Grove Street
Newton, MA 02466
1.800.782.1334
www.mckesson.com
The McKesson Diagnostics Exchange
The McKesson Diagnostics Exchange is an open, online test registry and workflow solution for information and evidence about MDx tests. Organizations that register with the McKesson Diagnostics Exchange are assigned a unique, five-digit alphanumeric McKesson Z-Code™ Identifier for each advanced diagnostics test so that each test can be accurately tracked, measured and reimbursed. The McKesson Diagnostics Exchange includes:
• Reference information about tests and how they are performed
• InterQual® Molecular Diagnostics clinical evidence summaries about test families
When combined into the McKesson Diagnostics Exchange workflow, this information enables payers, laboratories and providers to transparently identify and evaluate tests and to determine coverage policies. The McKesson Diagnostics Exchange helps reduce costs, increase efficiency and improve quality of care.
The McKesson Diagnostics Exchange helps:
Payers:
• Clearly adjudicate claims and more easily enforce coverage policies by eliminating variances in coding
• Reduce medical costs for unnecessary or miscoded tests
• Develop a well-informed Utilization Management program
Labs:
• More precisely identify and report on tests performed within clinical and financial systems
• Distinguish the efficacy of similar tests from other labs
Physicians:
• Precisely order tests
•Accurately report on appropriate services
Articles
Read More:
Unlocking the Human Genome: New Requirements for Identification and Classification
American Medical Association and McKesson Team up to Bring Transparency and Clarity to Molecular Diagnostic Testing
Understanding the Value of Advanced Diagnostics: Aligning Labs, Clinicians and Payers to Make Better Decisions